Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry?

KT Kaczmarek, K Protokowicz… - Journal of …, 2024 - Wiley Online Library
Neuropsychiatric conditions represent a major medical and societal challenge. The etiology
of these conditions is very complex and combines genetic and environmental factors. The …

[HTML][HTML] The role of biomarkers in clinical development of drugs for neuropsychiatric disorders-A pragmatic guide

D Umbricht, MJH Kas, GR Dawson - European Neuropsychopharmacology, 2024 - Elsevier
The failure rate of drugs being developed for neuropsychiatric indications remains high.
Optimizing drug discovery and development requires not only a better neurobiological …

Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis

J Seitz-Holland, Y Alemán-Gómez, KIK Cho… - …, 2024 - nature.com
Increasing evidence points toward the role of the extracellular matrix, specifically matrix
metalloproteinase 9 (MMP-9), in the pathophysiology of psychosis. MMP-9 is a critical …

The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design

AJM Chaves Filho, M Mottin, DB Lós, CH Andrade… - Biochimie, 2022 - Elsevier
Inflammation and an exacerbated immune response are widely accepted contributing
mechanisms to the genesis and progression of major neuropsychiatric disorders. However …

Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case …

H Yang, C Zhang, M Yang, J Liu, Y Zhang, D Liu… - BMC psychiatry, 2024 - Springer
Background Accumulating evidence has indicated that oxidative stress (OS) and matrix
metalloproteinase-9 (MMP-9) may contribute to the mechanism of schizophrenia. In the …

Plasma levels of matrix metalloproteinases in early psychosis, anxiety and depression: Evidence from the ALSPAC cohort

L Ghelfi, D Mongan, SR Susai, M Föcking… - Brain, Behavior, and …, 2025 - Elsevier
Background Converging evidence supports the role of Matrix Metalloproteinases (MMPs) in
psychiatric disorders. Originally identified as regulators of the extracellular matrix (ECM) …

Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow?

H Kawa, Z Ahmed, A Majid, R Chen - Neuropharmacology, 2024 - Elsevier
Ischaemic stroke characterises impulsive cerebral-region hypoxia due to deep intracerebral
arteriole blockage, often accompanied by permanent cerebral infarction and cognitive …

The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in …

Y Wang, X Zhang - Psychiatry Research, 2024 - Elsevier
Schizophrenia is a devastating psychiatric disorder that has detrimental effects on a
significant portion of the global population. Electroconvulsive therapy (ECT), as a safe and …

Dysregulation of synaptic plasticity markers in schizophrenia

N Keshri, H Nandeesha - Indian Journal of Clinical Biochemistry, 2023 - Springer
Schizophrenia is a mental disorder characterized by cognitive impairment resulting in
compromised quality of life. Since the regulation of synaptic plasticity has functional …

[HTML][HTML] Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options

V Dammavalam, D Rupert, M Lanio, Z Jin… - International Journal of …, 2024 - mdpi.com
Ischemic stroke is a leading cause of disability worldwide. While much of post-stroke
recovery is focused on physical rehabilitation, post-stroke dementia (PSD) is also a …